CoChat
Sign Up
Cited by 557Sleep and related disordersPsychometric Methodologies and TestingObstructive Sleep Apnea Research

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Psychometric properties of the Medical Outcomes Study Sleep measure

Hays, Ron D., Martin, Susan A., Sesti, Anne M., Spritzer, Karen L.·2005·Sleep Medicine
DOI 10.1016/j.sleep.2004.07.006
Open this paper in CoChat — free account

Abstract

Background and purpose Sleep is an active and highly organized biological process that is an important component of life. Self-report measures of sleep provide information that can be useful for characterizing the quality of sleep in subgroups of the population. A 12-item self-report sleep measure, the Medical Outcomes Study Sleep measure, was developed and evaluated previously in a sample of 3445 individuals with chronic illness.Patients and methods In this study, we evaluate the psychometric properties of the MOS Sleep measure in a nationally representative sample of 1011 US adults aged 18 and older and in a sample of 173 adults with neuropathic pain participating in a clinical drug trial.Results The average age of the general population sample was 46; 51% were female and 81% were white. The average age of the sample of adults with neuropathic pain was 72; 53% were female and 95% were white. Internal consistency reliability estimates for the MOS Sleep scales were 0.73 or higher, with the exception of the daytime somnolence scale in the US general population, which was 0.63. At baseline of the clinical trial, the neuropathic pain patients reported significantly more sleep disturbance and daytime somnolence, as well as less quantity and adequacy of sleep than patients in the general US population. The MOS Sleep scales were found to be responsive to change in the clinical trial with statistically significant improvements observed after administration of pregabalin for sleep disturbance (standardized response mean, SRM=-0.76, P=0.0007), shortness of breath (SRM=-0.20, P=0.0302), sleep adequacy (SRM=0.57, P=0.0014), sleep quantity (SRM=0.55, P=0.0086), and sleep problems (SRM=-0.62, P=0.0036).Conclusions This study provides further support for the reliability and validity of the MOS Sleep measure. The instrument can be used to assess important aspects of sleep perceived by adults in the general population or participating in clinical studies.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.sleep.2004.07.006

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 8 references

Research works printed but not linked: 1

  1. de la Loge, 2003, Psychometric properties of the MOS-Sleep scale using international clinical trial data, Qual Life Res, 12, 826

Cited by

Sorted by citations

Items 201–300 of 556

Related

See all

Metadata

Authors
Hays, R. D., Martin, S. A., Sesti, A. M., & Spritzer, K. L.
Affiliations
  • RAND Corporation (US)
  • Pfizer (United States) (US)
  • University of California, Los Angeles (US)
Corresponding author
Hays, Ron D.
ORCID
Venue
Sleep Medicine
Publisher
Elsevier BV
Published
2005-01
Volume
6
Issue
1
Pages
41-44
ISSN
1389-9457 (ISSN-L)
DOI
10.1016/j.sleep.2004.07.006
OpenAlex
W1969313589
Cited by
557
References
8
Citations by year
2026: 15 · 2025: 16 · 2024: 14 · 2023: 17 · 2022: 26 · 2021: 31 · 2020: 36 · 2019: 29 · 2018: 21 · 2017: 35 · 2016: 40 · 2015: 26 · 2014: 32 · 2013: 43 · 2012: 23
FWCI
14.71
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Sleep Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Pfizer
  • National Institutes of Health (5p20md000148-05)
  • National Institute on Aging (AG-02-004)
  • National Center on Minority Health and Health Disparities
  • National Institute on Minority Health and Health Disparities (P20-MD00148-01)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
  • Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
Keywords
sleep quality, daytime somnolence, sleep disorders, neuropathic pain, pregabalin, internal consistency, responsiveness to change, sleep adequacy, sleep quantity, psychometric validation
MeSH terms
Pregabalin, Adult, Aged, Aged, 80 and over, Anticonvulsants, Clinical Trials as Topic, Female, gamma-Aminobutyric Acid, Humans, Interviews as Topic, Male, Middle Aged, Neuralgia, Psychometrics, Respiration Disorders, Self-Assessment, Sleep, Reproducibility of Results, Treatment Outcome, Outcome Assessment, Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review